Gain Therapeutics, Inc. (GANX)
NASDAQ: GANX · Real-Time Price · USD
1.700
-0.160 (-8.60%)
At close: Jun 5, 2026, 4:00 PM EDT
1.790
+0.090 (5.29%)
After-hours: Jun 5, 2026, 6:33 PM EDT
Gain Therapeutics Market Cap
Gain Therapeutics has a market cap or net worth of $72.51 million as of June 5, 2026. Its market cap has increased by 28.44% in one year.
Market Cap
72.51M
Enterprise Value
56.64M
1-Year Change
28.44%
Ranking
Category
Stock Price
$1.70
Market Cap Chart
Since the IPO on March 18, 2021, Gain Therapeutics's market cap has decreased from $124.64M to $72.51M, a decrease of -41.82%. That is a compound annual growth rate of -9.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 4, 2026 | 79.34M | -35.94% |
| Dec 31, 2025 | 123.85M | 116.16% |
| Dec 31, 2024 | 57.29M | 16.03% |
| Dec 29, 2023 | 49.38M | 32.75% |
| Dec 30, 2022 | 37.19M | -42.34% |
| Dec 31, 2021 | 64.51M | -48.25% |
| Mar 18, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aardvark Therapeutics | 86.61M |
| Rallybio | 85.69M |
| Adicet Bio | 85.16M |
| Annovis Bio | 84.66M |
| NeurAxis | 83.64M |
| OS Therapies | 82.40M |
| Lixte Biotechnology Holdings | 81.33M |
| LeonaBio | 80.88M |